Journal of the American Academy of Dermatology
Volume 63, Issue 3 , Pages 420-429 , September 2010

Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study

  • Salvador Arias-Santiago, MD

      Affiliations

    • Dermatology Unit, San Cecilio University Hospital, Granada, Spain
    • Corresponding Author InformationReprint requests: Salvador Arias Santiago, MD, San Cecilio University Hospital, Av Dr. Oloriz 16, Granada, 18012, Spain.
    • ,
  • María Teresa Gutiérrez-Salmerón, PhD

      Affiliations

    • Dermatology Unit, San Cecilio University Hospital, Granada, Spain
    • ,
  • Luisa Castellote-Caballero, MD

      Affiliations

    • Radiology Unit, San Cecilio University Hospital, Granada, Spain
    • ,
  • Agustín Buendía-Eisman, PhD

      Affiliations

    • Dermatology Unit, San Cecilio University Hospital, Granada, Spain
    • ,
  • Ramón Naranjo-Sintes, PhD

      Affiliations

    • Dermatology Unit, San Cecilio University Hospital, Granada, Spain

,Accepted 4 October 2009.

References 

  1. Cotton SG, Nixon JM, Carpenter RG, Evans DW. Factors discriminating men with coronary heart disease from healthy controls. Br Heart J. 1972;34:458–464
  2. Hirsso P, Rajala U, Hiltunen L, Jokelainen J, Keinänen-kiukaanniemi S, Näyhä S. Obesity and low-grade inflammation among young Finnish men with early-onset alopecia. Dermatology. 2007;214:125–129
  3. Lesko SM, Rosenberg L, Shapiro S. A case-control study of baldness in relation to myocardial infarction in men. JAMA. 1993;269:998–1003
  4. Lotufo PA, Chae CU, Ajani UA, Hennekens CH, Manson JE. Male pattern baldness and coronary heart disease: the physician's health study. Arch Intern Med. 2000;160:165–177
  5. Ellis JA, Stebbing M, Harrap SB. Male pattern baldness is not associated with established cardiovascular risk factors in the general population. Clin Sci (Colch). 2001;100:401–404
  6. Mansouri P, Mortazavi M, Eslami M, Mazinani M. Androgenetic alopecia and coronary artery disease in women. Dermatol Online J. 2005;11:2
  7. Giltay EJ, Toorians AW, Sarabdjitsingh AR, de Vries NA, Gooren LJ. Established risk factors for coronary heart disease are unrelated to androgen-induced baldness in female-to-male transsexuals. J Endocrinol. 2004;180:107–112
  8. Adult Treatment Panel III . Executive summary on the third report of the national cholesterol education program (NECP): expert panel on detection, evaluation and treatment of high blood cholesterol in adults. JAMA. 2001;285:2486–2497
  9. Lameira D, Lejeune S, Mourad JJ. Metabolic syndrome: epidemiology and its risks. Ann Dermatol Venereol. 2008;135(Suppl):S249–S253
  10. Salaroli LB, Barbosa GC, Mill JG, Molina MC. Prevalence of metabolic syndrome in population-based study, Vitória, ES-Brazil. Arq Bras Endocrinol Metabol. 2007;51:1143–1152
  11. Martínez Candela J, Franch Nadal J, Romero Ortiz J, Cánovas Domínguez C, Gallardo Martín A, López Yepes ML. Predictive capacity of the diagnostic criteria of metabolic syndrome on the insulin-resistance and the coronary risk. Med Clin (Barc). 2007;129:601–606
  12. Calbo Mayo JM, Terrancle de Juan I, Fernández Jiménez P, Rodríguez Martín MJ, Martínez Díaz V, Santisteban López Y, et al. Prevalence of metabolic syndrome in the province of Albacete (Spain). Rev Clin Esp. 2007;2072:64–68
  13. Assmann G, Schulte H, Seedorf U. Cardiovascular risk assessment in the metabolic syndrome: results from the prospective cardiovascular Munster (PROCAM) study. Int J Obes (Lond). 2008;32(Suppl):S11–S16
  14. Matilainen V, Koskela P, Keinänen-Kiukaanniemi S. Early androgenetic alopecia as a marker of insulin resistance. Lancet. 2000;356:1165–1166
  15. Matilainen V, Laakso M, Hirsso P, Koskela P, Rajala U, Keinänen-Kiukaanniemi S. Hair loss, insulin resistance, and heredity in middle-aged women: a population-based study. J Cardiovasc Risk. 2003;10:227–231
  16. Klemp P, Peters K, Hansted B. Subcutaneous blood flow in early male pattern baldness. J Invest Dermatol. 1989;92:725–726
  17. Goldman BE, Fisher DM, Ringler SL. Transcutaneous PO2 of the scalp in male pattern baldness: a new piece to the puzzle. Plast Reconstr Surg. 1996;97:1109–1116
  18. Hirsso P, Laakso M, Matilainen V, Hiltunen L, Rajala U, Jokelainen J, et al. Association of insulin resistance linked diseases and hair loss in elderly men: Finnish population-based study. Cent Eur J Public Health. 2006;14:78–81
  19. Ahouansou S, Le Toumelin P, Crickx B, Descamps V. Association of androgenetic alopecia and hypertension. Eur J Dermatol. 2007;17:220–222
  20. Sainte Marie Y, Toulon A, Paus R, Maubec E, Cherfa A, Grossin M, et al. Targeted skin overexpression of the mineralocorticoid receptor in mice causes epidermal atrophy, premature skin barrier formation, eye abnormalities, and alopecia. Am J Pathol. 2007;171:846–860
  21. Arias-Santiago S, Gutiérrez-Salmerón MT, Castellote-Caballero L, Naranjo-Sintes R. Elevated aldosterone levels in patients with androgenetic alopecia. Br J Dermatol. 2009;161:1196–1198
  22. Sadighha A, Zahed GM. Evaluation of lipid levels in androgenetic alopecia in comparison with control group. J Eur Acad Dermatol Venereol. 2009;23:80–81
  23. Matilainen VA, Mäkinen PK, Keinänen-Kiukaanniemi SM. Early onset of androgenetic alopecia associated with early severe coronary heart disease: a population-based, case-control study. J Cardiovasc Risk. 2001;8:147–151
  24. Sharrett AR, Sorlie PD, Chambless LE, Folsom AR, Hutchinson RG, Heiss G, et al. Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence: the atherosclerosis risk in communities study. Am J Epidemiol. 1999;149:843–852
  25. Shahar E, Heiss G, Rosamond WD, Szklo M. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. Am J Epidemiol. 2008;167:676–683
  26. Johnsen SH, Mathiesen EB, Joakimsen O, Stensland E, Wilsgaard T, Løchen ML, et al. Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons; the Tromsø study. Stroke. 2007;38:2873–2880
  27. Dogramaci AC, Balci DD, Balci A, Karazincir S, Savas N, Topaloglu C, et al. Is androgenetic alopecia a risk for atherosclerosis?. J Eur Acad Dermatol Venereol. 2009;23:673–677
  28. Dusková M, Cermáková I, Hill M, Vanková M, Sámalíková P, Stárka L. What may be the markers of the male equivalent of polycystic ovary syndrome?. Physiol Res. 2004;53:287–294
  29. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med. 2009;361:1152–1163
  30. Fujimoto R, Morimoto I, Morita E, Sugimoto H, Ito Y, Eto S. Androgen receptors, 5alfa-reductase activity and androgen-dependent proliferation of vascular smooth muscle cells. J Steroid Biochem Mol Biol. 1994;50:169–174
  31. Ekmekci TR, Ucak S, Basat O, Koslu A, Altuntas Y. The presence of insulin resistance and comparison of various insulin sensitivity indices in women with androgenetic alopecia. Eur J Dermatol. 2007;17:21–25
  32. Reaven G. Banting lecture: role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607
  33. González-González JG, Mancillas-Adame LG, Fernández-Reyes M, Gómez-Flores M, Lavalle-González FJ, Ocampo-Candiani J, et al. Androgenetic alopecia and insulin resistance in young men. Clin Endocrinol (Oxf). 2009;71:494–499
  34. Sagastagoitia JD, Vacas M, Saez Y, Sáez de Lafuente JP, Santos M, Lafita M, et al. Lipoprotein (a), D-dimer and apolipoprotein A1 as markers of presence and severity of coronary disease. Med Clin (Barc). 2009;132:689–694
  35. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction; a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999;19:972–978
  36. Szpringer EA, Lutnicki KR, Zych IS. Polycystic ovary syndrome and hair unit function disturbances in dermatological practice. Wiad Lek. 2006;59:848–854
  37. Pugeat M, Ducluzeau PH, Mallion-Donadieu M. Association of insulin resistance with hyperandrogenia in women. Horm Res. 2000;54:322–326

 Funding sources: None.

 Conflicts of interest: None declared.

PII: S0190-9622(09)01347-4

doi: 10.1016/j.jaad.2009.10.018

Journal of the American Academy of Dermatology
Volume 63, Issue 3 , Pages 420-429 , September 2010

Article Tools